Literature DB >> 19273739

First-trimester prediction of hypertensive disorders in pregnancy.

Leona C Y Poon1, Nikos A Kametas, Nerea Maiz, Ranjit Akolekar, Kypros H Nicolaides.   

Abstract

This study aimed to establish a method of screening for pregnancy hypertension by a combination of maternal variables, including mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor in early pregnancy. The base-cohort population constituted of 7797 singleton pregnancies, including 34 case subjects who developed preeclampsia (PE) requiring delivery before 34 weeks (early PE) and 123 with late PE, 136 with gestational hypertension, and 7504 cases subjects (96.3%) who were unaffected by PE or gestational hypertension. Maternal history, uterine artery pulsatility index, mean arterial pressure, and pregnancy-associated plasma protein-A were recorded in all of the cases in the base cohort, but placental growth factor was measured only in the case-control population of 209 cases who developed hypertensive disorders and 418 controls. In each case the measured mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor were converted to a multiple of the expected median (MoM) after correction for maternal characteristics found to affect the measurements in the unaffected group. Early PE and late PE were associated with increased mean arterial pressure (1.15 MoM and 1.08 MoM) and uterine artery pulsatility index (1.53 MoM and 1.23 MoM) and decreased pregnancy-associated plasma protein-A (0.53 MoM and 0.93 MoM) and placental growth factor (0.61 MoM and 0.83 MoM). Logistic regression analysis was used to derive algorithms for the prediction of hypertensive disorders. It was estimated that, with the algorithm for early PE, 93.1%, 35.7%, and 18.3% of early PE, late PE, and gestational hypertension, respectively, could be detected with a 5% false-positive rate and that 1 in 5 pregnancies classified as being screen positive would develop pregnancy hypertension. This method of screening is far superior to the traditional approach, which relies entirely on maternal history.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273739     DOI: 10.1161/HYPERTENSIONAHA.108.127977

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  75 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

Review 2.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

3.  A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b).

Authors:  David M Haas; Corette B Parker; Deborah A Wing; Samuel Parry; William A Grobman; Brian M Mercer; Hyagriv N Simhan; Matthew K Hoffman; Robert M Silver; Pathik Wadhwa; Jay D Iams; Matthew A Koch; Steve N Caritis; Ronald J Wapner; M Sean Esplin; Michal A Elovitz; Tatiana Foroud; Alan M Peaceman; George R Saade; Marian Willinger; Uma M Reddy
Journal:  Am J Obstet Gynecol       Date:  2015-01-31       Impact factor: 8.661

Review 4.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

Review 5.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

6.  Arterial Resistance in Late First Trimester as a Predictor of Subsequent Pregnancy-Related Hypertension.

Authors:  Pralhad Kushtagi; Anoosha Emani
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

Review 7.  NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis.

Authors:  Atsushi Fukui; Mai Kamoi; Ayano Funamizu; Kohei Fuchinoue; Hitomi Chiba; Megumi Yokota; Rie Fukuhara; Hideki Mizunuma
Journal:  Reprod Med Biol       Date:  2015-04-11

8.  First-Trimester Inflammatory Markers for Risk Evaluation of Pregnancy Hypertension.

Authors:  Karuna Sharma; Ritu Singh; Manisha Kumar; Usha Gupta; Vishwajeet Rohil; Jayashree Bhattacharjee
Journal:  J Obstet Gynaecol India       Date:  2017-04-19

9.  Combination of serum angiopoietin-2 and uterine artery Doppler for prediction of preeclampsia.

Authors:  Ploynin Puttapitakpong; Vorapong Phupong
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

10.  First-trimester prediction of early preeclampsia: a possibility at last!

Authors:  Richard J Levine; Marshall D Lindheimer
Journal:  Hypertension       Date:  2009-03-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.